about
The Risk of Congenital Heart Anomalies Following Prenatal Exposure to Serotonin Reuptake Inhibitors-Is Pharmacogenetics the Key?Biological Tools to Study the Effects of Environmental Contaminants at the Feto-Maternal InterfaceThe placenta in toxicology. Part IV: Battery of toxicological test systems based on human placentaIncreased risk for congenital heart defects in children carrying the ABCB1 Gene C3435T polymorphism and maternal periconceptional toxicants exposureAssociations between ABCG2 gene polymorphisms and isolated septal defects in a Han Chinese populationStarD7 knockdown modulates ABCG2 expression, cell migration, proliferation, and differentiation of human choriocarcinoma JEG-3 cellsChemical analysis and transplacental transfer of oseltamivir and oseltamivir carboxylic acid in pregnant ratsIn silico prediction of inhibition of promiscuous breast cancer resistance protein (BCRP/ABCG2)Placental Origins of Chronic Disease.Characterisation of the clinical pharmacokinetics of actinomycin D and the influence of ABCB1 pharmacogenetic variation on actinomycin D disposition in children with cancer.Toxic effects of maternal zearalenone exposure on uterine capacity and fetal development in gestation rats.Polymorphisms in ABC transporter genes and concentrations of mercury in newborns--evidence from two Mediterranean birth cohortsAnthropometric, socioeconomic, and maternal health determinants of placental transfer of organochlorine compounds.Effect of Histone Deacetylase Inhibition on the Expression of Multidrug Resistance-associated Protein 2 in a Human Placental Trophoblast Cell Line.Antibiotic Treatment of Dogs and Cats during Pregnancy.Maternal intravenous administration of azithromycin results in significant fetal uptake in a sheep model of second trimester pregnancy.Ratio of cord to maternal serum PCB concentrations in relation to their congener-specific physicochemical properties.ATP-binding cassette efflux transporters in human placenta.Chemical exposure as etiology in developmental origin of adult onset human cancer.Suppression of trophoblast uterine spiral artery remodeling by estrogen during baboon pregnancy: impact on uterine and fetal blood flow dynamics.Human amniotic mesenchymal stromal cells (hAMSCs) as potential vehicles for drug delivery in cancer therapy: an in vitro study.Breast cancer-resistance protein (BCRP1) in the fetal mouse brain: development and glucocorticoid regulation.Drug Interactions at the Human Placenta: What is the Evidence?Maternal Smoking and the Risk of Cancer in Early Life - A Meta-AnalysisEffects of Antiviral Drugs on Organic Anion Transport in Human Placental BeWo Cells.Maternal use of drug substrates of placental transporters and the effect of transporter-mediated drug interactions on the risk of congenital anomalies.Fluid shear triggers microvilli formation via mechanosensitive activation of TRPV6Prescribing without evidence - pregnancy.A pregnancy physiologically based pharmacokinetic (p-PBPK) model for disposition of drugs metabolized by CYP1A2, CYP2D6 and CYP3A4Maternal obesity alters feto-placental cytochrome P4501A1 activity.Placental and fetal disposition of mercuric ions in rats exposed to methylmercury: role of Mrp2.ATP-binding cassette transporters in reproduction: a new frontier.The Lipid Transfer Protein StarD7: Structure, Function, and Regulation.Cannabidiol changes P-gp and BCRP expression in trophoblast cell linesTransplacental transfer and distribution of pravastatin.New approaches in human health risk assessment.The multidrug-resistance transporter ABCB5 is expressed in human placenta.Transplacental transfer of oseltamivir carboxylate.Surface functionality affects the biodistribution and microglia-targeting of intra-amniotically delivered dendrimers.Pharmacogenetics of drug-induced birth defects: what is known so far?
P2860
Q26741187-2C3A5A82-FBF3-4D48-8679-FA385774B75CQ26770358-2B177387-9B37-43AF-890D-C5D4EDA39053Q26991885-23C76F3B-43B6-4D38-89ED-52AA66804E49Q28385768-F509BDA6-AD0A-4FF8-8E01-01D53833307DQ28395070-1B7CC3E9-DF97-415F-A103-253A17FCE27FQ28482973-0A7DCB59-2CD6-4CEC-AD68-22693B280FB9Q28484222-997A900E-8FB8-415C-BD9C-A194B49A3231Q28540667-44DFC0EB-3CBB-48B6-979B-2B78DC610893Q30245567-6829A3AC-C224-4B4F-BFE4-6092FADFDF74Q30584978-850D596F-242C-4F9C-859F-951B8B77CB32Q33593487-A6BFC959-6495-4BD6-AF3D-95A0BFC25973Q33617898-65BCA351-B444-4892-8E2B-05D15BE74D8FQ33724597-396333DC-379B-4986-B8BB-62ABE4E0A32AQ33755618-E622DA86-92DC-4A99-B559-B06C5B75EE0DQ34495464-BB928B68-9610-41E3-9E4B-28E0DE07BD8EQ34596388-588F9C7B-494F-46C3-968C-B6B14FF15919Q34633343-0C7BD8B8-0908-4A95-A0D5-888290C435CCQ34843023-EC0ECDE0-5D6B-4443-B3CF-491520DF59C4Q35619948-F0A70578-E767-4A4A-8FA7-0EC28A9B48D5Q35994121-16E18AE8-5B3B-4B48-B13C-E7AEEAB7057DQ36004194-F5B882F4-B019-4B9E-A247-67B84AE72D2EQ36072110-0B0570EF-30CC-4A1A-A19B-AB5B8FC16342Q36081992-1D840070-C199-414D-90DE-05FBEAE118CBQ36185554-2569F85B-C995-4AC3-A8E0-9C1F0910DDBEQ36290804-0DD039A2-1D98-4E5A-9E80-4A433600E12AQ36306228-B385713B-11D8-4677-B41B-970F4CE11603Q36320446-8CA64D43-4AB1-4EF2-9C87-3F1C24E92A11Q36336002-4928BB86-33E5-41D3-9836-2B8F423538E0Q36390289-3804801F-77E5-40F4-94F4-07E01022BC7AQ36417384-771DC7E9-E94C-4EB1-A059-C9E977E17766Q36442832-0B756057-B315-4E2B-AB26-D42B6A84425CQ36585155-AE4201CB-EA2F-48F3-A8D1-1F11B64D62CCQ36790321-06FE3A22-7A25-4EFF-AB14-1565B323F06CQ37178591-F5FBD9DD-1164-4DC9-A96C-056BBF941BF0Q37478894-744E3DC6-2906-4D89-9BA1-A63BA3B8CC73Q37504203-0B3BA7AC-2715-4D7C-95FA-CD775220C725Q37541519-4DBB665A-A35D-49C8-A5AB-6FC4C7889056Q37572600-95A1B630-52D7-4926-94E0-3D27673802F5Q37737065-44824664-871F-4801-8937-506FB13EFAF5Q37869124-B36D47AC-4CAE-4F2E-976C-DEBA173A305D
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Drug transporters in the human blood-placental barrier.
@en
Drug transporters in the human blood-placental barrier.
@nl
type
label
Drug transporters in the human blood-placental barrier.
@en
Drug transporters in the human blood-placental barrier.
@nl
prefLabel
Drug transporters in the human blood-placental barrier.
@en
Drug transporters in the human blood-placental barrier.
@nl
P2860
P1476
Drug transporters in the human blood-placental barrier.
@en
P2093
Kirsi Vähäkangas
Päivi Myllynen
P2860
P304
P356
10.1111/J.1476-5381.2009.00336.X
P407
P577
2009-09-25T00:00:00Z